Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Jackson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|June 8, 2002
Alpha 4 integrin antagonistsDavid Y Jackson
Autonomic Neuroscience : Basic & Clinical|September 27, 2005
Involvement of alpha4 integrins in maintenance of cardiac sympathetic axonsKevin L Wingerd, William C Wayne, David Y Jackson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2002
Alpha 4 integrins and vascular cell adhesion molecule-1 play a role in sympathetic innervation of the heartKevin L Wingerd, Nichol L Goodman, Jason W Tresser, et al.
Developmental Biology|December 8, 2004
Integrin alpha4beta1 function is required for cell survival in developing retinaSergiu T Leu, Susan A L Jacques, Kevin L Wingerd, et al.
Journal of Medicinal Chemistry|July 26, 2002
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agentsNathan J P Dubree, Dean R Artis, Georgette Castanedo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophoresGeorgette M Castanedo, Fredrick C Sailes, Nathan J P Dubree, et al.
Molecular Pharmaceutics|September 23, 2015
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCsChristopher R Behrens, Edward H Ha, Lawrence L Chinn, et al.
Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|June 8, 2002
Alpha 4 integrin antagonistsDavid Y Jackson
Autonomic Neuroscience : Basic & Clinical|September 27, 2005
Involvement of alpha4 integrins in maintenance of cardiac sympathetic axonsKevin L Wingerd, William C Wayne, David Y Jackson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2002
Alpha 4 integrins and vascular cell adhesion molecule-1 play a role in sympathetic innervation of the heartKevin L Wingerd, Nichol L Goodman, Jason W Tresser, et al.
Developmental Biology|December 8, 2004
Integrin alpha4beta1 function is required for cell survival in developing retinaSergiu T Leu, Susan A L Jacques, Kevin L Wingerd, et al.
Journal of Medicinal Chemistry|July 26, 2002
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agentsNathan J P Dubree, Dean R Artis, Georgette Castanedo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophoresGeorgette M Castanedo, Fredrick C Sailes, Nathan J P Dubree, et al.
Molecular Pharmaceutics|September 23, 2015
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCsChristopher R Behrens, Edward H Ha, Lawrence L Chinn, et al.
Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.
Pageof 1